---
figid: PMC7506081__fonc-10-01788-g004
figlink: pmc/articles/PMC7506081/figure/F4/
number: F4
caption: In tumor cells, the glucose uptake is significantly increased. SREBPs can
  promote glycogen production and accelerate glycolysis by activating the PFKFB. glycolysis
  leads to the massive production of pyruvate. Pyruvate can be converted into lactic
  acid and also participates in the tricarboxylic acid cycle. The tricarboxylic acid
  cycle produces citrate, which can be used as raw materials for lipid synthesis and
  cholesterol synthesis. Citrate transports mitochondria into the cytoplasm through
  SLC25A1. In tumors, activated SREBPs can promote the activity of multiple fatty
  acid synthases and accelerate the formation of fatty acids. Excess fatty acids can
  be converted into LDs and phospholipids. On the one hand, it is used for the proliferation
  of tumor cells and on the other hand to avoid lipotoxicity. SREBPs promote cholesterol
  absorption by activating LDLR, and mir-33, which is co-transcribed with SREBPs,
  can also inhibit the gene expression of transporters, thereby inhibiting cholesterol
  efflux. Natural drugs ultimately inhibit the activity of SREBPs through a variety
  of ways, including inhibiting gene transcription, reducing the transport of SREBPs,
  and reducing the maturation of SREBPs protein.
pmcid: PMC7506081
papertitle: Role of the Sterol Regulatory Element Binding Protein Pathway in Tumorigenesis.
reftext: Tao Jiang, et al. Front Oncol. 2020;10:1788.
pmc_ranked_result_index: '22877'
pathway_score: 0.9515869
filename: fonc-10-01788-g004.jpg
figtitle: In tumor cells, the glucose uptake is significantly increased
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7506081__fonc-10-01788-g004.html
  '@type': Dataset
  description: In tumor cells, the glucose uptake is significantly increased. SREBPs
    can promote glycogen production and accelerate glycolysis by activating the PFKFB.
    glycolysis leads to the massive production of pyruvate. Pyruvate can be converted
    into lactic acid and also participates in the tricarboxylic acid cycle. The tricarboxylic
    acid cycle produces citrate, which can be used as raw materials for lipid synthesis
    and cholesterol synthesis. Citrate transports mitochondria into the cytoplasm
    through SLC25A1. In tumors, activated SREBPs can promote the activity of multiple
    fatty acid synthases and accelerate the formation of fatty acids. Excess fatty
    acids can be converted into LDs and phospholipids. On the one hand, it is used
    for the proliferation of tumor cells and on the other hand to avoid lipotoxicity.
    SREBPs promote cholesterol absorption by activating LDLR, and mir-33, which is
    co-transcribed with SREBPs, can also inhibit the gene expression of transporters,
    thereby inhibiting cholesterol efflux. Natural drugs ultimately inhibit the activity
    of SREBPs through a variety of ways, including inhibiting gene transcription,
    reducing the transport of SREBPs, and reducing the maturation of SREBPs protein.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PFKFB3
  - OGT
  - AKT2
  - AKT3
  - AKT1
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - KEAP1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - RASA1
  - MTOR
  - FOXO1
  - STAT3
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - FCGR2A
  - FCGR2C
  - FCGR2B
  - PAEP
  - FASN
  - ACACB
  - ACACA
  - SLC25A1
  - ACLY
  - ABCA1
  - LDLR
  - Glucose
  - Foxol
  - Lactate
  - Pyruvate
  - Acetyl-CoA
  - Citrate
  - TSA
  - Isoprene
  - SqualeneCholesterol
  - Succinate
  - Cholesterol
genes:
- word: PFKFB3
  symbol: PFKFB3
  source: hgnc_symbol
  hgnc_symbol: PFKFB3
  entrez: '5209'
- word: OGT
  symbol: OGT
  source: hgnc_symbol
  hgnc_symbol: OGT
  entrez: '8473'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: Keapl
  symbol: KEAP1
  source: hgnc_symbol
  hgnc_symbol: KEAP1
  entrez: '9817'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: GAP
  symbol: GAP
  source: hgnc_alias_symbol
  hgnc_symbol: RASA1
  entrez: '5921'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Foxol
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: CD32
  symbol: CD32
  source: bioentities_symbol
  hgnc_symbol: FCGR2A
  entrez: '2212'
- word: CD32
  symbol: CD32
  source: bioentities_symbol
  hgnc_symbol: FCGR2C
  entrez: '9103'
- word: CD32
  symbol: CD32
  source: bioentities_symbol
  hgnc_symbol: FCGR2B
  entrez: '2213'
- word: PEP
  symbol: PEP
  source: hgnc_alias_symbol
  hgnc_symbol: PAEP
  entrez: '5047'
- word: FASN
  symbol: FASN
  source: hgnc_symbol
  hgnc_symbol: FASN
  entrez: '2194'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: SLC25A1
  symbol: SLC25A1
  source: hgnc_symbol
  hgnc_symbol: SLC25A1
  entrez: '6576'
- word: ACLY
  symbol: ACLY
  source: hgnc_symbol
  hgnc_symbol: ACLY
  entrez: '47'
- word: АВСА1
  symbol: ABCA1
  source: hgnc_symbol
  hgnc_symbol: ABCA1
  entrez: '19'
- word: →LDLR
  symbol: LDLR
  source: hgnc_symbol
  hgnc_symbol: LDLR
  entrez: '3949'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
- word: Foxol
  source: ''
  identifier: ''
- word: Lactate
  source: MESH
  identifier: D019344
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Acetyl-CoA
  source: MESH
  identifier: D000105
- word: Citrate
  source: MESH
  identifier: C102006
- word: TSA
  source: MESH
  identifier: C070842
- word: Isoprene
  source: MESH
  identifier: C005059
- word: SqualeneCholesterol
  source: MESH
  identifier: D013185
- word: Succinate
  source: MESH
  identifier: D013386
- word: Cholesterol
  source: MESH
  identifier: D002784
diseases: []
figid_alias: PMC7506081__F4
redirect_from: /figures/PMC7506081__F4
figtype: Figure
---
